Rocuronium has dose-dependent rapid to intermediate onset of action, and intermediate duration of effects. Because of its rapid onset of action, rocuronium is approved for use in rapid sequence intubation, which
Saphris may interact with alpha blockers,anticholinergic/antispasmodicdrugs, fluvoxamine, paroxetine, amiodarone, dofetilide, pimozide, procainamide, quinidine, sotalol, antibiotics, alcohol,antihistamines, theophylline, tramadol,antidepressants, drugs for sleep or anxiety, muscle relaxants, and narcotics. Chec...
- Currently receiving treatment with other active substances known to prolong QT interval such as antiarrhythmics of class IA (quinidine and procainamide ) and class III (dofetilide, amiodarone and sotalol), cisapride and terfenadine; antipsychotic agents such as pimozide; antidepressants such as cital...
There are no clinical data to support the advice given below, but from consideration of first principles one might expect the following interactions: Drugs such as quinidine, disopyramide, procainamide, phenothiazines, antihistamines, tricyclic antidepressants and erythromycin may be associated with QT-inte...
Nexterone injection is used to help keep the heart beating normally in people with life-threatening heart rhythm disorders of the ventricles (the lower chambers of the heart that allow blood to flow out of the heart). Nexterone is used to treat or prevent ventricular tachycardia or ventricular ...
LEVAQUIN® should be avoided in patients with known prolongation of the QT interval, patients with uncorrected hypokalemia, and patients receiving Class IA (quinidine, procainamide), or Class III (amiodarone, sotalol) antiarrhythmic agents. Elderly patients may be more susceptible to drug-associated ...
procainamide, quinidine, sotalol, antibiotics, alcohol,antihistamines, theophylline, tramadol,antidepressants, drugs for sleep or anxiety, muscle relaxants, and narcotics. Check labels ofallergyor cough-and-cold products for ingredients that cause drowsiness. Tell your doctor all medications you are taking...
patients with ongoing proarrhythmic conditions such as uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia, and in patients receiving Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents. Elderly patients may be more susceptible to...
patients with ongoing proarrhythmic conditions such as uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia, and in patients receiving Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents. ...
patients with ongoing proarrhythmic conditions such as uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia, and in patients receiving Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents ...